Key Details
Price
$7.84Annual ROE
-61.09%Beta
1.96Events Calendar
Next earnings date:
Mar 28, 2025Recent quarterly earnings:
Oct 31, 2024Recent annual earnings:
Mar 28, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Feb 13, 25 Maxim Group
BuyFeb 11, 25 Scotiabank
Sector OutperformJun 1, 23 Baird
OutperformMay 24, 22 BTIG
BuyMay 24, 22 B. Riley Securities
NeutralJan 24, 22 B. Riley Securities
BuyApr 21, 21 B. Riley Securities
BuyApr 21, 21 B. Riley FBR
BuyNov 25, 20 Roth Capital
BuyNov 25, 20 Maxim Group
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
INmune Bio doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for INmune Bio?
- Does INmune Bio pay dividends?
- What sector is INmune Bio in?
- What industry is INmune Bio in?
- What country is INmune Bio based in?
- When did INmune Bio go public?
- Is INmune Bio in the S&P 500?
- Is INmune Bio in the NASDAQ 100?
- Is INmune Bio in the Dow Jones?
- When was INmune Bio's last earnings report?
- When does INmune Bio report earnings?
- Should I buy INmune Bio stock now?
What is the ticker symbol for INmune Bio?
The ticker symbol for INmune Bio is NASDAQ:INMB
Does INmune Bio pay dividends?
No, INmune Bio does not pay dividends
What sector is INmune Bio in?
INmune Bio is in the Healthcare sector
What industry is INmune Bio in?
INmune Bio is in the Biotechnology industry
What country is INmune Bio based in?
INmune Bio is headquartered in United States
When did INmune Bio go public?
INmune Bio's initial public offering (IPO) was on February 4, 2019
Is INmune Bio in the S&P 500?
No, INmune Bio is not included in the S&P 500 index
Is INmune Bio in the NASDAQ 100?
No, INmune Bio is not included in the NASDAQ 100 index
Is INmune Bio in the Dow Jones?
No, INmune Bio is not included in the Dow Jones index
When was INmune Bio's last earnings report?
INmune Bio's most recent earnings report was on Oct 31, 2024
When does INmune Bio report earnings?
The next expected earnings date for INmune Bio is Mar 28, 2025
Should I buy INmune Bio stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions